[Toxic epidermal necrolysis. Epidemiologic, clinic and therapeutic aspects at Cotonou University and National Teaching Hospital]

Ann Fr Anesth Reanim. 2006 May;25(5):505-9. doi: 10.1016/j.annfar.2006.01.012. Epub 2006 Mar 20.
[Article in French]

Abstract

Introduction: Toxic epidermal necrolysis (TEN) is usually a drug-induced disease, involving vital or functional prognosis with 20 to 30% mortality rates.

Objectives: The aim was to collect cases of TEN in an intensive care unit in Cotonou National University and Teaching Hospital, and describe epidemiologic, clinical, therapeutic and evolutive patterns.

Study design: Retrospective and descriptive study over five years.

Patients and methods: The medical report-forms of patients admitted between January 1998 and December 2002, for toxic dermatitis with total skin injury area more than 10% were reviewed.

Results: Fourteen patients with TEN were identified. The average incidence was three cases per year, accounting for 0.25% of the admissions in the unit. Sulphonamides (n=4), antituberculous drugs (n=2), penicillin (n=3) were the main cause of TEN. In five patients, the cause was not found. Self-medication was found in 7 patients. Total skin injury area reached from 26 to 87%. Mucosal and viscera injury occurred in respectively 11 and 9 patients. The treatment was usual as in extended burns. Four patients died (28.5%). The average time before hospitalisation was 11.4 days.

Conclusion: The growing-awareness of people can prevent/reduce the morbidity and improve the prognosis of TEN.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Antitubercular Agents / adverse effects
  • Case Management
  • Child
  • Child, Preschool
  • Female
  • France / epidemiology
  • Hospital Mortality
  • Hospitals, University / statistics & numerical data*
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Length of Stay / statistics & numerical data
  • Male
  • Penicillins / adverse effects
  • Retrospective Studies
  • Self Medication
  • Stevens-Johnson Syndrome / epidemiology*
  • Stevens-Johnson Syndrome / etiology
  • Stevens-Johnson Syndrome / pathology
  • Stevens-Johnson Syndrome / therapy
  • Sulfonamides / adverse effects

Substances

  • Antitubercular Agents
  • Penicillins
  • Sulfonamides